Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Aset Lancar
Keuangan
Harga Saham
USD
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 15.25B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Aset Lancar
Perubahan
Tanggal
Agilent
USD 4.76B
148M
2026-03
Align Technology
USD 2.66B
7.62M
2026-06
Bio Techne
USD 744.4M
56.35M
2026-06
Bio-Rad Laboratories
USD 3.02B
78.4M
2026-06
Bruker
USD 2.22B
121.4M
2026-06
Celltrion
KRW 481.57B
10.97B
2026-03
Charles River Laboratories
USD 1.53B
40.3M
2026-06
Cspc Pharmaceutical
CNY 22.25B
359.48M
2025-12
Danaher
USD 13.38B
554M
2026-06
Dentsply International
USD 1.93B
83M
2026-06
Deva Holding AS
TRY 9.13B
1.61B
2023-09
Dianthus Therapeutics
USD 897.54M
222.37M
2026-06
Divis Laboratories Ltd
INR 110.96B
12.53B
2026-03
Edwards Lifesciences
USD 6.82B
590.2M
2026-06
Illumina
USD 2.83B
96M
2026-06
Intuitive Surgical
USD 12.33B
807.5M
2026-06
IQVIA Holdings
USD 6.23B
6M
2026-06
Kangmei Pharma
CNY 6.8B
225.83M
2026-03
Knight Therapeutics
CAD 394.84M
5.86M
2025-12
Laboratorios Farma
EUR 509.33M
128.63M
2023-12
Laboratory Of America
USD 3.81B
743.9M
2026-06
Malin Corporation
EUR 62.6M
26.7M
2024-12
Medical Developments International
AUD 33.75M
1.79M
2025-12
Mesa Laboratories
USD 105.63M
8.2M
2025-12
Mettler Toledo International
USD 1.35B
15.48M
2026-06
Myriad Genetics
USD 289M
23.8M
2026-06
Neuren Pharmaceuticals
AUD 332.23M
11.98M
2025-12
OraSure Technologies
USD 222.94M
17.84M
2026-06
Organigram Holdings
CAD 250.09M
6.46M
2026-03
Ovoca Bio
EUR 2.07M
510K
2025-12
Pacific Biosciences Of California
USD 338.64M
30.88M
2026-06
Pharma Mar
EUR 280.95M
7.5M
2026-06
Qiagen NV
USD 1.66B
116.37M
2026-06
Quest Diagnostics
USD 2.84B
278M
2026-06
Quidel
USD 1.38B
400K
2026-06
Repligen
USD 1.2B
39.19M
2026-06
Revvity
USD 2.3B
169.4M
2026-06
Sartorius
EUR 1.64B
280M
2026-06
Sino Biopharmaceutical
CNY 33.82B
9.13B
2025-06
Thermo Fisher Scientific
USD 23.36B
1.05B
2026-06
Tilray
USD 729.32M
28.18M
2025-09
Waters
USD 3.9B
186M
2026-06
Zealand Pharma A/S
15.02B
652.12M
2026-03
Zz Pientze Pharmaceu
CNY 11.43B
728.95M
2026-03
×